Deal Street

Àrgentil Capital Partners Invests In Nigerian Healthcare
Àrgentil Capital Partners Invests In Nigerian Healthcare

Investment banking firm Àrgentil Capital Partners has made an undisclosed amount of equity investment in Nigerian healthcare company Sygen Pharmaceuticals Limited through investment vehicle Consumer Growth Partners along with other undisclosed investors.

Incorporated in 2019, Sygen Pharmaceuticals Limited has produced and distributed pharmaceutical products for more than half a century in Nigeria. Prior to this, Sygen acquired operating assets of Nigerian German Chemicals in 2019. Àrgentil invests in small and medium size enterprises through Àrgentil Principal Investment Portfolio II whose key focus areas include Nigeria.

Popular

Annual Membership

$60

(billed annually)

Access To 12-Month WT Membership

Access To WT's Conferences & Events

Access To All WT's Research Reports On Africa

Access To Podcasts, Video Content & Recordings

Access To All Premium Newsletters

Unlimited Access To WT's Content Archive

Subscribe Now